Neurologic manifestations of toxoplasmosis in AIDS

Seminars in Neurology

Volumn 19, Issue 2, 1999, Pages 201-211

  Cohen, Bruce A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AIDS; Neurologic; Opportunistic infections; Toxoplasmosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY SPECIFICITY; CENTRAL NERVOUS SYSTEM INFECTION; HUMAN; LIFE CYCLE; NEUROLOGIC DISEASE; OPPORTUNISTIC INFECTION; PARASITEMIA; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTOZOAL INFECTION; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0032834448     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040838     Document Type: Review

References (91)

1. Mariuz P, Bosler E, Luft BJ. Toxoplasmosis. In: Berger JR, Levy RM, eds. AIDS & the nervous system. Philadelphia: Lippincott-Raven, 1997:641-659
2. Richards FO Jr, Kovacs JA, Luft BJ. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infec Dis 1995;21(Suppl 1):S49-S56
3. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992;15:211-222
4. Raffi F, Aboulker J-P, Michelet C, et al. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997;11:177-184
5. Renold C, Sugar A, Chave J-P, et al. Toxoplasmic encephalitis in patients with the acquired Immunodeficiency syndrome. Medicine 1992;71:224-239
6. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency Syndrome. N Engl J Med 1992;327:1643-1648
7. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993;269:76-77
8. Glaser CA, Angulo FJ, Rooney JA. Animal-associated opportunistic infections among persons Infected with the human immunodeficiency virus. Clin Infect Dis 1994;18:14-24
9. Grant IH, Gold WM, Rosenblum M, et al. Toxoplasma gondii serology in HIV-infected patients: Thedevelopment of central nervous system toxoplasmosis in AIDS. AIDS 1990;4:519-521
10. Zangerle R, Allenberger F, Pohl P, et al. High risk of developing toxoplasmic encephalitis in AIDS Patients seropositive for Toxoplasma gomlii. Med Microbiol Immunol 1991;180:59-66
11. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neruologic Diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994;44:1892-1900
12. Oksenhendler E, Charreau I, Tournerie C, et al. Toxoplasma gondii infection in advanced HIV Infection. AIDS 1994;8:483-487
13. Gray F, Gherardi R, Keohane C, et al. Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS). Neuropathol Appl Neurobiol 1988;14:365-380
14. Chimelli L, Rosemberg S, Hahn MD, et al. Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV): A report of 252 autopsy cases from Brazil. Neuropathol Appl Neurobiol 1992;18:478-488
15. Lang W, Miklossy J, Deruaz JP, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases form Switzerland. Acta Neuropathol 1989;77:379-390
16. Cornford ME, Holden JK, Boyd MC, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): Report of 39 autopsies from Vancouver. British Columbia. Can J Neurol Sci 1992;19:442-452
17. Burns DK, Risser RC, White CL III. The neuropathology of human immunodeficiency virus infection. Arch Pathol Lab Med 1991;115:1112-1124
18. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiecy virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 1991;22: 700-710
19. Navia BA, Petitio CK, Gold JWM, et al. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients. Ann Neurol 1986;19:224-238
20. Luft BJ, Brooks RG, Conley FK, et al. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 1984;252:913-917
21. Farkash AE, Maccabee PJ, Sher JH, et al. CNS toxoplasmosis in acquired immune deficiency syndrome: A clinical-pathologicalradiological review of 12 cases. J Neurol Neurosurg Psychiatry 1986;49:744-748
22. Artigas J, Grosse G, Niedobitek F, et al. Severe toxoplasmic ventriculomeningoencephalomyelitis in two AIDS patients following treatment of cerebral toxoplasmic granuloma. Clin Neuropathol 1994;13:120-126
23. Eggers C, Vortmeyer A, Emskotter T. Cerebral toxoplasmosis in a patient with the acquired immunodeficiency syndrome presenting as obstructive hydrocephalus. Clin Neuropathol 1995;14:51-54
24. Falangola MF, Reichler BS, Petito CK. Histopathology of cerebral toxoplasmosis in human immunodeficiency virus infection: A comparison between patients with early-onset and late-onset acquired immunodeficiency syndrome. Hum Pathol 1994;25: 1091-1097
25. Gray F, Gherardi R, Wingate E, et al. Diffuse encephalitic cerebral toxoplasmosis in AIDS. J Neurol 1989;236:273-277
26. Hunter CA, Remington JS. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis 1994;170:1057-1067
27. Nath A, Hobson DE, Russell A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 1993;8:107-112
28. Maggi P, de Mari M, De Blasi R, et al. Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis. Mov Disord 1996;4:434-436
29. Dewey RB Jr, Jankovic J. Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol 1989;46: 862-867
30. Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology 1987;37:37-41
31. Noel S, Guillaume M-P, Telerman-Toppet N, et al. Movement disorders due to Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg 1992;92:148-156
32. Carrazana E, Rossitch E, Samuels MA. Parkinson symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry 1989;52:1445-1446
33. Tolge CF, Factor SA. Focal dystonia secondary to cerebral toxoplasmosis in a patient with AIDS. Mov Disord 1991;6:69-72
34. Carrazana E, Rosssitch E Jr, Masrtinez J. Unilateral akathisia in a patient with AIDS and a toxoplasmosis subthalamic abscess. Neurology 1989;39:449-450
35. Koppel BS, Daras M. Rubral tremor due to midbrain toxoplasmosis abscess. Mov Disord 1990;5:254-256
36. Daras M, Koppel BS, Samkoff L, et al. Brainstem toxoplasmosis in patients with acquired immunodeficiency syndrome. J Neuroimag 1994;4:85-90
37. Orefice G, Volpe G, Liuzzi G, et al. Weber's syndrome due to a possible solitary brainstem toxoplasmosis as a presenting sign of AIDS. Eur J Neurol 1995;2:375-377
38. Kure K, Harris C, Morin LS, et al. Solitary midbrain toxoplasmosis and olivary hypertrophy In a patient with acquired immunodeficiency syndrome. Clin Neuropathol 1989;8:35-40
39. Arendt G, Figge C, Neuen-Jakob E, et al. Two cases of cerebral toxoplasmosis in AIDS patients mimicking HIV-related dementia. J Neurol 1991;238:439-442
40. Linard F, Beau P, Silvestre D, et al. Toxoplasmosis with an onset of isolated psychiatric disturbance (12 cases). Int Conf AIDS 8:101, abstract 7316, July 19-24, 1992
41. Caramello P, Forno B, Lucchini A, et al. Meningoencephalitis caused by Toxoplasma gondii diagnosed by isolation from cerebrospinal fluid in an HIV-positive patient. Scand J Infect Dis 1993;25:663-666
42. Nolle-Salas J, Ricart C, D'Olhaberriague L, et al. Hydrocephalus: An unusual CT presentation of cerebral toxoplasmosis in a patient with acquired immunodeficiency syndrome. Eur Neurol 1987;27:130-132
43. Trenkwalder P, Trenkwalder C, Feiden W, et al. Toxoplasmosis with early intracerebral hemorrhage in a patient with the acquired immunodeficiency syndrome. Neurology 1992;42:436-438
44. Gonzales GR, Herskovitz S, Rosenblum M, et al. Central pain from cerebral abscess: Thalamic syndrome in AIDS patients with toxoplasmosis. Neurology 1992;42:1107-1109
45. Grassi MP, Borella M, Clerici F, et al. Reversible bilateral opercular syndrome secondary to AIDS-associated cerebral toxoplasmosis. Ital J Neurol Sci 1994;15:115-117
46. Milligan S, Katz MS, Craven PC, et al. Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome. Am J Med 1984;77:760-764
47. Mehren M, Burns PJ, Mamani F, et al. Toxoplasmic myelitis mimicking intramedullary spinal cord tumor. Neurology 1988;38: 1648-1650
48. Herskovitz S, Siegel SE, Schneider AT, et al. Spinal cord toxoplasmosis in AIDS. Neurology 1989;39:1552-1553
49. Overhage JM, Greist A, Brown DR. Conus medullaris syndrome resulting from Toxoplasma gondii infection in a patient with the acquired immunodeficiency syndrome. Am J Med 1990;89: 814-815
50. Harris TM, Smith RR, Bognanno JR, et al. Toxoplasmic myelitis in AIDS: Gadolinium-enhanced MR. J Comput Assist Tomog 1990;14:809-811
51. Resnick DK, Comey CH, Welch WC. Isolated toxoplasmosis of the thoracic spinal cord in a patient with acquired immunodeficiency syndrome. J Neurosurg 1995;82:493-496
52. Fairley CK, Wodak J, Benson E. Spinal cord toxoplasmosis in a patient with human immunodeficiency virus infection. Int J STD AIDS 1992;3:366-368
53. Vyas R, Ebright JR. Toxoplasmosis of the spinal cord in a patient with AIDS: Case report and review. Clin Infect Dis 1996;23: 1061-1065
54. Gherardi R, Baudrimont M, Lionnet F, et al. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: A clinical and pathological study. Ann Neurol 1992;32: 535-542
55. Ramsey R, Gean AD. Central nervous system toxoplasmosis. Neuroimag Clin North Am 1997;7:171-186
56. Rovira MJ, Post MJD, Bowen BC. Central nervous system infections in HIV-positive persons. Neuroimag Clin North Am 1991; 1:179-200
57. Post JDP, Sheldon JJ, Hensley GT, et al. Central nervous system disease in acquired immunodeficiency syndrome: Prospective correlation using CT MR imaging, and pathologic studies. Radiology 1986;158:141-148
58. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990;73:720-724
59. RuizA, Ganz WI, Post JD, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994;15:1885-1894
60. 201TI single-photon emission computed tomography. Am J Radiol 1994; 163:417-421
61. Catafau AM, Sola M, Lomena FJ, et al. Hyperperfusion and early technetium-99m-HMPAO SPECT appearance of central nervous system toxoplasmosis. J Nucl Med 1994;35:1041-1043
62. Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34:567-575
63. Pierce MA, Johnson MD, Maciunas RJ, et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995;123:594-598
64. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:525-531
65. Beaman MH, McCabe RE, Wong S-Y, et al. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone, 1995:2455-2475
66. Potasman S, Resnick L, Luft BJ, et al. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiencysyndrome (AIDS). Ann Intern Med 1988;108:49-51
67. Parmley SF, Goebel FD, Remington JS. Detection of Toxoplasma gondii in cerebrospinal fluid fromAIDS patients by polymerase chain reaction. J Clin Microbiol 1992;30:3000-3002
68. van de Ven ES, Galama J, Kraaijeveld C, et al. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1992;16:661-666
69. Novati R, Castagna A, Morsica G, et al. Polymerase chain reaction for toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994;8:1691-1694
70. Eggers C, Grob U, Klinker H, et al. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis with AIDS. J Neurol 1995;242:644-649
71. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Mol Microbiol 1996;45:472-476
72. Cohn JA, McMeeking A, Cohen W, et al. Evaluation of the policy of empiric treatment of suspected toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989;86:521-527
73. Haverkos HW. Assessment of therapy for toxoplasmic encephalitis. Am J Med 1987;82:907-914
74. Carbone LG, Bendixen B, Appel GB. Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. Am J Kidney Dis 1988; 12:72-75
75. Sahai J, Heimberger T, Collins K, et al. Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: A reminder [letter]. Am J Med 1988;84:791-792
76. Reboli AC, Mandler HD. Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis [letter]. Clin Infect Dis 1992;15:556-557
77. Hedriana HL, Mitchell JL, Brown GM, et al. Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. J Reprod Med 1993;38:747-750
78. Dannemann BR, Israelski DM, Remington JS. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med 1988;148:2477-2482
79. Dannemann B, McCutchan A, Israelski D, et al. Treatment of toxoplasmic encephalitis in patients with AIDS: A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 1992;116:33-43
80. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000
81. Katlama C, De Wit S, O'Doherty E, et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996;22:268-275
82. Wynn RF, Leen CLS, Brettle RP. Azithromycin for cerebral toxoplasmosis in AIDS [letter]. Lancet 1993;341:243-244
83. Saba J, Morlat P, Raffi F, et al. Pyrimethamine plus azithramycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur J Clin Microbiol Infect Dis 1993;12:853-856
84. Kovacs JA. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 1992;340:637-638
85. Spencer CM, Goa KL. Atovaquone: A review of its pharmacological properties and theraputic efficacy in oportunistic infections. Drugs 1995;50:176-196
86. Laissy JP, Soyer P, Parlier C, et al. Persistant enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: Predictive value for subsequent recurrence. Am J Neuroradiol 1994;15:1773-1778
87. Leport C, Raffi F, Matheron S, et al. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 1988;84:94-100
88. Podzamczer D, Miro JM, Bolao F, et al. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1995;123:175-180
89. Kovacs JA. Toxoplasmosis in AIDS: Keeping the lid on. Ann Intern Med 1995;123:230-231
90. Jones JL, Hanson DL, Chu SY, et al. Toxoplasmic encephalitis in HIV-infected persons: Risk factors and trends. AIDS 1996;10: 1393-1399
91. Kaplan JE, Masur H, Holmes KK. USPHS/IDSA. Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morbid Mortal Wkly Rep 1997;46:RR-12